tirzepatide 2ml vial – 60 mg Mounjaro 2.5 mg / 0.5

Marketing was another topic discussed in the Center for Medicine in the Public Interest white paper, which stated many websites selling off-brand GLP-1s fail to say that the products were not FDA approved or falsely claim their product was either FDA approved or a generic medication

Kkesi O, Ioja E, Szab Z, Kardos J, Hja L

But some compounding pharmacies are now trying to continue this practice after a drug shortage endsskirting FDA safety regulations and oversight, and potentially jeopardizing patient health. Compounding pharmacies lower regulatory compliance costs can contribute to a lower price point, which is frequently emphasized in direct-to-consumer advertising such as a recent Super Bowl ad for compounded GLP-1s watched by 123 million people

Infused over 3-5 hours

The gradual escalation protocol for both medications is specifically designed to minimise side effects and tolerability